We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-10.84%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$484M
AUM Growth
-$79.2M
Cap. Flow
+$24K
Cap. Flow %
0%
Top 10 Hldgs %
67.5%
Holding
115
New
3
Increased
18
Reduced
5
Closed
18
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
BC icon
Brunswick
BC
+$25.8M
2
THO icon
Thor Industries
THO
+$8.74M
3
GPGI icon
GPGI Inc
GPGI
+$6.08M
4
INVE icon
INVE Technologies, Inc. Common Stock
INVE
+$3.09M
5
MIST icon
Milestone Pharmaceuticals
MIST
+$1.61M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$20M
2
TCDA
Tricida, Inc. Common Stock
TCDA
+$7.12M
3
CDXS icon
Codexis
CDXS
+$4.12M
4
SONO icon
Sonos
SONO
+$3.7M
5
COUR icon
Coursera
COUR
+$1.24M

Sector Composition

Rank Sector Weight
1 Healthcare 18.92%
2 Miscellaneous 16.8%
3 Consumer Discretionary 16.68%
4 Financials 15.64%
5 Industrials 14.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ONDS icon
26
Ondas Inc
ONDS
$3.7B
$3.68M 0.76%
682,352
+2,600
+0.4% +$18K
2021 Q3
3 quarters
AXP icon
27
American Express
AXP
$212B
$3.47M 0.72%
25,000
– –
2019 Q4
10 quarters
JPM icon
28
JPMorgan Chase
JPM
$891B
$3.38M 0.7%
30,000
– –
2019 Q4
10 quarters
HLTH icon
29
DELISTED
Cue Health Inc. Common Stock
HLTH
$3.2M 0.66%
1,000,000
– –
2021 Q3
3 quarters
MIST icon
30
Milestone Pharmaceuticals
MIST
$98.9M
$3.04M 0.63%
512,500
+262,500
+105% +$1.61M
2021 Q4
2 quarters
FNCH icon
31
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2.3M 0.48%
27,014
– –
2021 Q1
5 quarters
FAZE
32
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$2.24M 0.46%
225,000
– –
2021 Q2
4 quarters
BRIV
33
DELISTED
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$2.19M 0.45%
225,000
– –
2021 Q3
3 quarters
LBTYK icon
34
Liberty Global Class C
LBTYK
$2.69B
$1.54M 0.32%
69,618
– –
2019 Q4
10 quarters
HCAR
35
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$1.48M 0.3%
150,000
– –
2022 Q1
1 quarter
CUE icon
36
Cue Biopharma
CUE
$136M
$1.38M 0.29%
18,500
+100
+0.5% +$11.7K
2019 Q4
10 quarters
LIQT icon
37
LiqTech
LIQT
$12.3M
$1.23M 0.25%
340,445
+70,326
+26% +$604K
2020 Q1
9 quarters
MXCT icon
38
MaxCyte
MXCT
$134M
$1.16M 0.24%
250,000
– –
2021 Q3
3 quarters
TEKK
39
DELISTED
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
$990K 0.2%
100,000
– –
2021 Q4
2 quarters
ICCC icon
40
ImmuCell
ICCC
$95.9M
$883K 0.18%
101,594
+30,521
+43% +$265K
2021 Q2
4 quarters
QUMU
41
DELISTED
Qumu Corp.
QUMU
$604K 0.12%
750,000
+250,000
+50% +$304K
2021 Q1
5 quarters
DNTH icon
42
Dianthus Therapeutics
DNTH
$4.17B
$581K 0.12%
30,275
– –
2020 Q1
9 quarters
RTX icon
43
RTX Corp
RTX
$252B
$577K 0.12%
6,000
– –
2020 Q2
8 quarters
BKTI icon
44
BK Technologies
BKTI
$251M
$528K 0.11%
39,880
– –
2021 Q2
4 quarters
LBTYA icon
45
Liberty Global Class A
LBTYA
$2.74B
$484K 0.1%
22,989
– –
2019 Q4
10 quarters
VATE icon
46
INNOVATE Corp
VATE
$84.7M
$475K 0.1%
27,480
– –
2020 Q1
9 quarters
ARKOW icon
47
DELISTED
ARKO Corp Warrant
ARKOW
$473K 0.1%
333,333
– –
2020 Q4
6 quarters
CELC icon
48
Celcuity
CELC
$2.95B
$455K 0.09%
50,000
– –
2021 Q1
5 quarters
CRIS icon
49
Curis
CRIS
$1.23M
$430K 0.09%
1,092
+125
+13% +$52.1K
2020 Q4
6 quarters
LHX icon
50
L3Harris
LHX
$44.8B
$387K 0.08%
1,600
– –
2019 Q4
10 quarters
1
2
3 4 5

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q2 2022 Portfolio in Review

As of Q2 2022, Bleichroeder LP held 115 positions worth $484M, down 14% from $563M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Bleichroeder LP's Q2 2022 filing shows 3 new, 18 increased, 5 reduced and 18 closed positions. Its largest new stake was SaverOne 2014 Ltd: 14 shares worth $272K. The largest sale was Linde, an estimated $20M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

  • Bleichroeder LP's largest Q2 2022 buy was SaverOne 2014 Ltd: 14 shares worth $272K.
  • Bleichroeder LP added most to Brunswick in Q2 2022, an estimated $25.8M increase.
  • Bleichroeder LP's biggest Q2 2022 reduction was Linde, cutting an estimated $20M.
  • Bleichroeder LP fully exited Codexis in Q2 2022, selling an estimated $4.12M.
  • Bleichroeder LP's ten largest holdings make up 68% of its $484M portfolio in Q2 2022.
  • Bleichroeder LP opened 3 new positions and closed 18 in Q2 2022.
  • Bleichroeder LP's portfolio value fell 14% quarter-over-quarter to $484M.

Based on Bleichroeder LP's 13F filing for Q2 2022, filed 10 Aug 2022.